Arkolith/Insider Trading/MNPR/Form 4

Cittadine Andrew

Chief Operating OfficerMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Apr 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2025Option exercise(M)2K——43K
Mar 31, 2025Tax withholding(F)744$36.41$27K42K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2024Option exercise(M)2K—$050K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-010810) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Monopar Therapeutics

Build

Ask your agent about MNPR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-25-010810"
Ask your agent
Use Arkolith to summarize insider buying and selling at Monopar Therapeutics
over the last 90 days and cite the filings.